The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Trump-Xi China Summit 2026: Trade Tensions, Taiwan, and Iran Take Center Stage
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook
Sony Forecasts Lower 2027 Profit Despite Strong Music and Sensor Growth
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump
Asian Stocks Slip as Korea’s KOSPI Tumbles Amid Iran Conflict and Chip Sector Profit-Taking
K+S Raises 2026 Earnings Outlook After Strong Q1 Results
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Norway Core Inflation Hits 3.2% in April, Fueling Interest Rate Hike Expectations
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs
Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors
ECB Signals Possible Interest Rate Move if Inflation Outlook Fails to Improve 



